| Primary |
| Hypertension |
55.8% |
| Drug Use For Unknown Indication |
16.5% |
| Cardiac Disorder |
3.2% |
| Blood Pressure Increased |
2.8% |
| Diabetes Mellitus |
2.8% |
| Product Used For Unknown Indication |
2.1% |
| Cardiac Failure |
1.8% |
| Cardiac Failure Congestive |
1.8% |
| Angina Pectoris |
1.4% |
| Arrhythmia |
1.4% |
| Blood Pressure |
1.4% |
| Blood Pressure Management |
1.4% |
| Osteoarthritis |
1.4% |
| Essential Hypertension |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Right Ventricular Failure |
1.1% |
| Smoking Cessation Therapy |
1.1% |
| Acute Myeloid Leukaemia |
0.7% |
| Anticoagulant Therapy |
0.7% |
| Arthritis |
0.7% |
|
| Pharmaceutical Product Complaint |
15.5% |
| Angioedema |
10.3% |
| Renal Failure |
7.2% |
| Therapeutic Response Unexpected With Drug Substitution |
7.2% |
| Vision Blurred |
7.2% |
| Swollen Tongue |
5.2% |
| Tremor |
5.2% |
| Cough |
4.1% |
| Drug Hypersensitivity |
4.1% |
| Product Substitution Issue |
4.1% |
| Rash |
4.1% |
| Vomiting |
4.1% |
| Malaise |
3.1% |
| Overdose |
3.1% |
| Prostatic Specific Antigen Increased |
3.1% |
| Renal Failure Acute |
3.1% |
| Urticaria |
3.1% |
| Asphyxia |
2.1% |
| Dizziness |
2.1% |
| Drug Ineffective |
2.1% |
|
| Secondary |
| Hypertension |
50.9% |
| Drug Use For Unknown Indication |
7.2% |
| Product Used For Unknown Indication |
6.5% |
| Cardiac Failure Congestive |
5.7% |
| Diabetes Mellitus |
3.8% |
| Myocardial Infarction |
3.8% |
| Gastric Ulcer Haemorrhage |
2.8% |
| Blood Pressure Increased |
2.6% |
| Ill-defined Disorder |
2.3% |
| Angina Pectoris |
1.6% |
| Ischaemic Cardiomyopathy |
1.6% |
| Cerebrovascular Accident Prophylaxis |
1.3% |
| Diabetic Neuropathy |
1.3% |
| Lung Transplant |
1.3% |
| Renal Failure |
1.3% |
| Sepsis |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Hyperlipidaemia |
1.1% |
| Pain |
1.1% |
| Prophylaxis |
1.1% |
|
| Pharmaceutical Product Complaint |
17.3% |
| Tremor |
9.8% |
| Renal Failure |
9.0% |
| Dyspnoea |
6.8% |
| Liver Disorder |
6.8% |
| Vomiting |
6.8% |
| Drug Hypersensitivity |
4.5% |
| Hyperkalaemia |
4.5% |
| Tension |
4.5% |
| Intentional Overdose |
3.8% |
| Therapeutic Response Unexpected With Drug Substitution |
3.8% |
| Drug Ineffective |
3.0% |
| Stevens-johnson Syndrome |
3.0% |
| Weight Increased |
3.0% |
| Adverse Event |
2.3% |
| Fatigue |
2.3% |
| Glucose Tolerance Impaired |
2.3% |
| Pneumonia |
2.3% |
| Syncope |
2.3% |
| Trigeminal Neuralgia |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.8% |
| Drug Use For Unknown Indication |
19.9% |
| Hypertension |
9.9% |
| Diabetes Mellitus |
4.1% |
| Pain |
3.2% |
| Depression |
2.1% |
| Multiple Myeloma |
2.1% |
| Blood Cholesterol Increased |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Cardiac Disorder |
1.8% |
| Osteoporosis |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Anxiety |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Hormone Replacement Therapy |
1.6% |
| Nuclear Magnetic Resonance Imaging |
1.6% |
| Prophylaxis |
1.5% |
| Atrial Fibrillation |
1.4% |
| Blood Pressure |
1.4% |
| Asthma |
1.2% |
|
| Vomiting |
13.4% |
| Weight Decreased |
11.7% |
| Weight Increased |
8.8% |
| Myocardial Infarction |
7.8% |
| Pain |
5.9% |
| Type 2 Diabetes Mellitus |
5.3% |
| Nausea |
5.1% |
| Urinary Tract Infection |
4.9% |
| Vision Blurred |
4.5% |
| Death |
3.8% |
| Drug Ineffective |
3.6% |
| Wheezing |
3.6% |
| Pneumonia |
3.3% |
| Breast Cancer Female |
3.2% |
| Sepsis |
3.0% |
| Somnolence |
2.5% |
| Thrombocytopenia |
2.5% |
| Myalgia |
2.3% |
| Oedema Peripheral |
2.3% |
| Pain In Extremity |
2.3% |
|
| Interacting |
| Blood Pressure Increased |
66.7% |
| Spinal Pain |
33.3% |
|
| Blood Pressure Increased |
100.0% |
|
